In collaboration with Oscar Abilez, we are testing the effect of chronic opioids in vascularized 2D and 3D organoids. We are particularly interested in the development of iPSC-derived cardiomyocytes and endothelial cells and how their fate is modified by drugs and environmental factors.

vascularized organoids

Vascularized 2D organoids treated with fentanyl in the presence and absence of naloxone.

beating spheres

Vascularized 3D organoid in which  the TNNT2 promoter is driving GFP expression to identify cardiomyocytes.